RKLB

Rocket Lab USA
D

RKLB

Rocket Lab USA balance sheet 2019–2026

Rocket Lab USA had 4.61B USD in cash and short-term investments on 30 September 2026, against total debt of 118.57M USD: net cash of 4.49B USD.

Total assets Total liabilities Shareholders' equity

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
Latest
Q3 FY2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
FY2021
31 Dec 2021
FY2020
31 Dec 2020
FY2019
31 Dec 2019
Cash and equivalents
4.45B828.66M271.04M162.52M242.52M690.96M52.79M95.88M
Short-term investments
160.29M187.92M147.95M82.26M229.28M0.000.000.00
4.61B1.02B418.99M244.77M471.79M690.96M52.79M95.88M
Cash growth
+371.77%+142.63%+71.17%-48.12%-31.72%+1,208.83%-44.94%—
Receivables
118.31M122.99M111.53M61.80M47.47M19.01M10.65M8.25M
Inventory
280.89M158.41M119.07M107.86M92.28M47.90M26.14M14.16M
Other current assets
245.77M9.84M4.99M14.26M7.63M2.10M914.00K6.35M
Total current assets
5.25B1.37B692.62M476.72M662.29M774.76M93.11M124.63M
Property, plant and equipment
534.69M423.74M262.90M219.80M152.37M93.76M76.73M65.73M
Long-term investments
0.0082.25M60.69M79.25M9.19M0.000.000.00
Goodwill and intangibles
609.27M430.50M129.66M139.11M150.71M100.80M14.48M1.33M
Goodwill
301.42M205.75M71.02M71.02M71.02M43.31M3.13M—
Intangible assets
307.85M224.75M58.64M68.09M79.69M57.49M11.35M1.33M
Other non-current assets
169.82M20.56M35.47M22.83M10.66M5.67M1.14M3.50M
Total assets
6.57B2.32B1.18B941.21M989.12M980.85M187.87M195.19M
Accounts payable
0.0072.70M53.06M29.30M12.08M3.49M3.37M6.46M
Deferred revenue
0.00195.44M216.16M139.34M108.34M59.75M26.13M0.00
Short-term debt
0.000.0012.05M17.76M2.91M2.83M0.000.00
Other current liabilities
614.12M21.24M17.95M15.04M22.25M11.00M7.77M25.48M
Total current liabilities
614.12M334.48M339.53M223.37M162.94M96.31M48.42M31.94M
Long-term debt
118.57M154.11M389.44M87.59M100.04M97.30M0.0026.03M
Other non-current liabilities
23.05M12.95M5.10M3.94M3.01M60.03M278.86M1.00K
Lease obligations, current
0.000.000.000.000.000.000.000.00
Lease obligations, long-term
0.0099.84M66.94M71.34M49.83M28.30M27.30M0.00
Total liabilities
766.14M602.62M801.89M386.67M315.92M282.40M354.58M57.97M
Common stock and paid-in capital
64.00K54.00K50.00K49.00K48.00K45.00K8.00K0.00
Retained earnings
-1.19B-1.01B-813.70M-623.53M-440.96M-305.01M-187.69M-132.69M
Accumulated other comprehensive income
-10.33M-1.96M-2.81M1.54M1.14M1.31M1.06M-79.00K
Shareholders' equity
5.80B1.72B382.45M554.54M673.21M698.45M-166.71M137.22M
Minority interest
0.000.000.000.000.000.000.000.00
118.57M253.96M468.42M176.69M152.78M128.43M27.30M26.03M
Net cash
4.49B762.62M-49.43M68.09M319.01M562.53M25.49M69.85M
Working capital
4.64B1.03B353.10M253.35M499.35M678.46M44.70M92.69M
Book value per share
8.903.240.771.151.441.54-0.370.34
Tangible book value
5.19B1.29B252.80M415.43M522.49M597.65M-181.19M135.89M
Tangible book value per share
7.962.430.510.861.121.32-0.400.34
Current ratio
8.554.082.042.134.068.041.923.90
Debt to equity
0.020.151.220.320.230.18—0.19

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

Common questions about Rocket Lab USA's cash and debt

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.